Skip to content

The impact of gum disease on the levels of a cardiovascular disease marker in the body

The impact of periodontal inflammation on endothelial function assessed by circulating levels of asymmetric dimethylarginine: a single-blinded randomized clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN13626790
Enrollment
140
Registered
2022-07-08
Start date
2018-06-06
Completion date
Unknown
Last updated
2023-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Generalized periodontitis with no risk for endothelial dysfunction Oral Health

Interventions

This was a 6-month, randomized controlled trial, including 140 patients between 41 and 63 years old, diagnosed with severe periodontitis, free from cardiovascular disease (CVD), and traditional cardio

Sponsors

University of Bari Aldo Moro
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged between 41 years old and 63 years old 2. Diagnosis of generalized periodontitis

Exclusion criteria

Exclusion criteria: 1. Patients presenting with dental implants, orthodontic bands and ulcers 2. Patients who received periodontal treatment within 12 months prior to the start of the study 3. Patients who received systemic antibiotics within the last 6 months 4. Pregnancy or breastfeeding mothers 5. History of diabetes or a fasting glucose level greater than 126 mg/dl 6. History of cardiovascular disease 7. Patients with any systemic disease: 7.1. Diabetes mellitus 7.2. Cardiovascular disease 7.3. Kidney disease 7.4. Liver disease 7.5. Lung disease 8. Patients with cardiovascular risk factors and active smokers were excluded to minimize any confounding effect of conditions that may influence endothelial function

Design outcomes

Primary

MeasureTime frame
Asymmetric dimethylarginine levels in blood measured by enzyme-linked immunosorbent assay (ELISA, DLD Diagnostika, Hamburg, Germany) at baseline, 3 and 6 months

Secondary

MeasureTime frame
1. Fibromuscular dysplasia (FMD) of the right brachial artery measured using ultrasound at baseline, 3 and 6 months 2. Periodontal indices using a periodontal probe at baseline, 3 and 6 months

Countries

Albania

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026